At a Glance
| 5-MeO-DiBF | 1cP-LSD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 80–110 mg | 75–150 µg |
| Total Duration | 0.5–1 hrs | 4.1–8 hrs |
| Routes | oral | oral |
| Effects | 32 documented | 77 documented |
5-MeO-DiBF, a Psychedelic, and 1cP-LSD, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 28 documented effects in common, with 4 effects unique to 5-MeO-DiBF and 49 unique to 1cP-LSD. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 5-MeO-DiBF | 1cP-LSD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 80–110 mg | 75–150 µg |
| Total Duration | 0.5–1 hrs | 4.1–8 hrs |
| Routes | oral | oral |
| Effects | 32 documented | 77 documented |
| Level | 5-MeO-DiBF | 1cP-LSD |
|---|---|---|
| Threshold | 20 mg | 15 µg |
| Light | 50–80 mg | 25–75 µg |
| Common | 80–110 mg | 75–150 µg |
| Strong | 110–140 mg | 150–300 µg |
| Heavy | 140 mg | 300 µg |
5-MeO-DiBF
1cP-LSD
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.